Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase

By | 2018-07-16T10:07:49+00:00 July 16th, 2018|Back Pain, Mesenchymal Stem Cells, Stem Cells|Comments Off on Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase

Adipose tissue-derived mesenchymal stem cells (AT-MSCs) offer potential as a therapeutic option for chronic discogenic low back pain (LBP) because of their immunomodulatory functions and capacity for cartilage differentiation. The goal of this study was to assess the safety and tolerability of a single intradiscal implantation of combined AT-MSCs and hyaluronic acid (HA) derivative in patients with chronic discogenic LBP.

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-Low-Back-Pain.pdf” title=”MSC’s in Low Back Pain”]

About the Author:

Related Posts